ShareProphets

The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Join ShareProphets at less than 2p per article

> All the big AIM fraud exposés

> 300 articles and podcasts a month

> Hot share tips

> Original investigations by our experienced team

> No ads, no click-bait, no auto-play videos

Find out more

Tom Winnifrith BearCast - Advanced Oncotherapy Special

By Tom Winnifrith | Wednesday 3 June 2015


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


It seems as if some folks think that questioning the share price of Advanced Oncotherapy (AVO) is akin to attacking the fight against cancer. It is not. But in this podcast I just have a few questions.


Filed under:


Never miss a story.




This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.


More on AVO


Comments

7 comments

  1. Thing is tho Tom , this share is a bit different . People like to have a few “feel good” shares in their portfolio . Its a bit like supporting a charity , feeling wise . Anyone owning the share IS helping the cause because it is creating ownership and more demand for the share ………. without which a placing would not be possible at all……. and without which this project could not raise the funds needed to creat the machine that does the curing.

    It may be overvalued , it may not ………………. just like OPTI and its plan to sell naturally occuring bacteria to folk in Yogurt form as a health aid . Okay its got patents , but plenty of companies have found that a hard one to police where naturally occuring bacteria are concerned . Just look at the farming industry and its use of lacto Bacilli strains inocculated into grass silage to obtain a favorable fermentation .

    Lets see you do a hatchet job on OPTI………… their cash burn is so low that they cant really be doing anything much at all let alone any research ……… its all PR bluster In my view . Its a contract with no named contractor and NO contract value . Sounds more like a MOU to me . Where is the substance . Anyone can gather a few patents . Some companies spend their whole life garnering patents and never do owt with them .


  2. Daniel Victor

    I agree about the shares,but if they could get a machine in a clinic in Harley Street,with even a half-decent chance of treating cancer,they’d literally be the only game in town for some patients.Then they could charge an awful lot.

  3. Agree with comments about the valuation but I’m not sure people are getting carried away. The recent doubling of the share price came on the back of a $40m sale of its LIGHT treatment into one Chinese hospital. Considering some of the other price movements on AIM that doesn’t seem unreasonable to me.

  4. As I’ve suggested elsewhere, this is one risky punt. But if it comes off – wow! Not for the faint-hearted , though.

  5. I get confused using this whole site and about it’s reliability more than any other coin-tossers – particularly as Tom likes to regard it as much better than competition. Tom makes a special bearcast on AVO to pan its value and prospects, some weeks after Malcolm Stacey was bigging it up as a buy. Malcolm’s was the first note I had seen on this and yes I did buy a few days later and yes I am sitting on a loss! Might have been better had Tom gave the negative argument sooner.

    And don’t get me started on allowing any share to be focus of chartist Mr Mir. I am a long suffering Kea shareholder who were trying to raise £3m through Primary Bid. Success, or failure, was going to have dramatic consequences. A few days before the closing date of PB Zak had it in very positive chart terms – no account of reality. The £3m Primary Bid failed and the shares are currently suspended…..

  6. Paul

    as we both know charting is all cobblers. As to MS & i disagreeing we never have a house view here – we allow all writers to say what they think. Sometimes they disagree. I think having a range of views a good thing – folks must choose which authors they follow & which they ignore. But debate is healthy.

    T

  7. Take responsibility for your own investments Paul.
    I presume you’re not paying for anything from shareprophets so don’t see how you can blame writers when the shares they promote don’t rise as soon as you act on their views.


Enter your comment below. Fields marked * are required. You must preview your comment first before finally posting.


Site by Everywhen